Roger S Goody Selected Research

GDP dissociation inhibitor 1

4/2005	Chemical biology of protein lipidation: semi-synthesis and structure elucidation of prenylated RabGTPases.
10/2003	Structure of Rab GDP-dissociation inhibitor in complex with prenylated YPT1 GTPase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger S Goody Research Topics

Disease

9	Neoplasms (Cancer) 07/2020 - 12/2004
6	Infections 04/2014 - 08/2010
2	Choroideremia 01/2013 - 06/2004
2	Osteoporosis 05/2012 - 03/2006
2	Legionnaires' Disease (Legionnaire's Disease) 11/2011 - 08/2010
2	Intellectual Disability (Idiocy) 04/2005 - 10/2003
1	Parkinson Disease (Parkinson's Disease) 10/2014
1	Blindness (Hysterical Blindness) 01/2013
1	Metrorrhagia (Spotting) 11/2012
1	Oculocerebrorenal Syndrome (Lowe Syndrome) 04/2012
1	Virus Diseases (Viral Diseases) 01/2010
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2010
1	Disease Progression 01/2010

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 04/2014 - 06/2004
3	Monomeric GTP-Binding ProteinsIBA 01/2016 - 10/2012
2	Retinaldehyde (Retinal)IBA 01/2013 - 06/2004
2	LipidsIBA 08/2010 - 12/2004
2	EnzymesIBA 01/2010 - 03/2006
2	GDP dissociation inhibitor 1IBA 04/2005 - 10/2003
2	Terpenes (Terpenoids)IBA 12/2004 - 10/2003
1	Pharmaceutical PreparationsIBA 07/2020
1	ras ProteinsIBA 01/2018
1	alpha-SynucleinIBA 10/2014
1	rab GTP-Binding ProteinsIBA 01/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	KetonesIBA 11/2012
1	GuanosineIBA 08/2010
1	GTP Phosphohydrolases (GTPases)IBA 08/2010
1	phosphatidylinositol 4-phosphateIBA 08/2010
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2010
1	NucleosidesIBA 01/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2010
1	NucleotidesIBA 04/2005

Therapy/Procedure

3	Therapeutics 01/2018 - 12/2009